According to Stratistics MRC, the Global Drug Modeling Software Market is accounted for $6,707.84 million in 2020 and is expected to reach $14,483.76 million by 2028 growing at a CAGR of 10.1% during the forecast period. Factors such as increasing prevalence of various lifestyle diseases, advancement of information technology, and rising expenditure on healthcare are driving the growth of the market. However, stringent regulations associated with the development and testing of drugs are hampering the growth of the market.
Request for a Free Sample Copy of Report at www.strategymrc.com/report/drug-modeling-software-market/request-sample
Based on the application, the drug discovery and development segment is anticipated to expand at a rapid pace during the forecast period owing to the need for better therapeutic agents for different diseases. By geography, North America is going to have high growth during the forecast period which can be attributed to the availability of high end technologies and modern infrastructure which helps in carrying out drug modeling effectively.
Some of the key players profiled in the Drug Modeling Software Market include Schrodinger, Inc., Biognos Ab, Crown Bioscience Inc, Acellera Ltd, Dassault Systemes , Chemical Computing Group Ulc, Genedata Ag , Nimbus Therapeutics, Leadscope Inc, and Compugen Ltd.
• Drug Discovery and Development
• Simulation Software
• Disease Modeling
• Predictive Analysis of Drug Targets
• Computational Physiological Medicine
• Cellular Simulation
• Medical Imaging
End Users Covered:
• Research Institutes
• Educational Institutes
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
If Any Query? Ask Our Industry Expert at www.strategymrc.com/report/drug-modeling-software-market/request-customization
Explore the list of attractive markets during this time of Pandemic @ www.strategymrc.com/covid-19-impact-reports
StrategyMRC research reports and publications are routed to help clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects. We track 30+ industries and cover 800 market segments.
Stratistics Market Research Consulting